Treatment of osteocarcinoma with alpha-1-antitrypsin or secretory leucocyte protease inhibitor

摘要

The present invention relates to the treatment of cancerous conditions in mammals by the administration to the site of disease compositions containing serine protease inhibitor. The cancerous conditions include osteocarcinomas, melanoma, Karopsi sarcoma and keratosis. The compositions are also useful to relieve the pain associated with the disease.